Understanding Pine Bark Extract as an Alternative Treatment (UPBEAT) Study
Trial ID or NCT#
Status
Purpose
The purpose of this study is to investigate the efficacy of Flavangenol® (Toyo Shinyaku, Japan), a pine bark extract, in lowering blood pressure and improving glycemic control and plasma lipoprotein profile.
Official Title
Cardiovascular Effects of Pine Bark Extract
Eligibility Criteria
- * Systolic blood pressure between 125 and 159 mmHg and diastolic blood pressure (DBP) \< 100 mmHg* Body mass index (BMI) 25.0-34.9* Triglycerides (TG) \< 450 mg/dL* Low Density Lipoprotein (LDL) \< 200 mg/dL* Fasting blood glucose (FBG) \< 126 mg/dL
- * DBP \> 95 mmHg* LDL \> 170 mg/dL* TG \> 300 mg/dL* FBG \> 110 mg/dL
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
Rebbeca Drieling
6507236528
View on ClinicalTrials.gov